BioSpace News Archive

Thermo Fisher Scientific Inc. today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per common share, payable on January 15, 2019, to shareholders of record as of December 17, 2018.

Mirati Therapeutics, Inc. today announced dosing of the first patient under its collaboration agreement with BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160) in a Phase 1b clinical trial to assess the safety and tolerability, pharmacokinetics and preliminary anti-tumor activity of Mirati’s sitravatinib in combination with BeiGene’s investigational anti-PD1 antibody, tislelizumab, in patients with advanced solid tumors.

Akebia Therapeutics, Inc. today announced financial results for the third quarter ended September 30, 2018.

- Announces Western Institutional Review Board Approval for Select INSPIRE 2.0 Study Sites -

Recognized at National Philanthropy Day event on November 5, 2018

Carmell Therapeutics today announced its plans to participate in both the 2018 Biotech and Money Investival Showcase and the 2018 MedTech Strategist Innovation Summit.

Alpine Immune Sciences, Inc. today provided a corporate update and reported financial results for the third quarter ended September 30, 2018

Cresco Labs today announced key growth milestones achieved ahead of the company’s expected public listing on the Canadian Securities Exchange (“CSE”).

Phonak Audéo™ Marvel and Phonak Virto™ B-Titanium both named CES 2019 Innovation Awards Honorees

Synergy Pharmaceuticals Inc. today reported its financial results and business update for the three months ended September 30, 2018.